Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Grape Seed Proanthocyanidins Enhance Time-Dependent HO-1 Activation and Improve Redox Homeostasis in Obesity-Induced Hepatic Dysfunction.

Antioxidants (Basel, Switzerland)·2026
Same author

Sex and photoperiod shape hepatic redox homeostasis in diet-induced obesity in association with a melatonin-NRF2-circadian regulatory axis.

Free radical biology & medicine·2026
Same author

Grape Seed Flavanols Restore Peripheral Clock of White Adipose Tissue in Obese Rats Under Circadian Alterations.

Nutrients·2025
Same author

PDB-CAT: A user-friendly tool to classify and analyze PDB protein-ligand complexes.

Protein science : a publication of the Protein Society·2025
Same author

Circannual Rhythms Affect the Bioavailability of Phenolic Compounds from Grape Seed Proanthocyanidins Extract Differently in Healthy and Obese Fischer 344 Rats.

Journal of agricultural and food chemistry·2025
Same author

Influence of Different Hemodialysis Biocontrols on the Achievement of the Convective Volume.

Blood purification·2025

Related Experiment Video

Updated: May 23, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Development of docking-based 3D-QSAR models for PPARgamma full agonists.

Laura Guasch1, Esther Sala, Cristina Valls

  • 1Grup de Recerca en Nutrigenòmica, Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Campus de Sescelades, C/ Marcel. lí Domingo s/n, 43007 Tarragona, Catalonia, Spain.

Journal of Molecular Graphics & Modelling
|April 17, 2012
PubMed
Summary

Researchers explored peroxisome proliferator-activated receptor gamma (PPARγ) agonists for diabetes and skin conditions. A 3D-QSAR study of tyrosine derivatives revealed predictive models for PPARγ activity and binding, offering insights for drug improvement.

Related Experiment Videos

Last Updated: May 23, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Area of Science:

  • Medicinal Chemistry
  • Molecular Pharmacology
  • Computational Drug Design

Background:

  • Peroxisome proliferator-activated receptor gamma (PPARγ) is a key target for type II diabetes treatment.
  • PPARγ's therapeutic potential in skin cancer and other dermatological conditions is under investigation.
  • Understanding structure-activity relationships is crucial for developing effective PPARγ agonists.

Purpose of the Study:

  • To investigate the relationship between the structure of tyrosine-based PPARγ full agonists and their trans-activation activity.
  • To develop predictive 3D-QSAR models for PPARγ activity and binding affinity.
  • To gain structural insights for enhancing PPARγ agonist bioactivity.

Main Methods:

  • Docking simulations to align conformations of tyrosine-based PPARγ agonists.
  • Three-dimensional quantitative structure-activity relationship (3D-QSAR) analysis.
  • Validation of models using Pearson-R values for transactivation and binding affinity.

Main Results:

  • Highly predictive 3D-QSAR models were generated.
  • Pearson-R values of 0.86 for transactivation activity and 0.90 for binding affinity were achieved.
  • The models align well with the structural features of the PPARγ binding pocket.

Conclusions:

  • The developed 3D-QSAR models accurately predict PPARγ agonist activity and binding.
  • These findings provide valuable structural insights for designing improved PPARγ full agonists.
  • The study supports PPARγ as a promising target for diabetes and skin disease therapeutics.